tweenvest

Miro Sciences Ltd (ASX: MSX)

Health Care · Biotechnology · AU

AU$0.04

+2.44% today · -68.9% 1Y

Public summary
A free snapshot of Miro Sciences Ltd, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Miro Sciences Ltd (ASX: MSX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $11.09M and employs 9 people.

Over the last twelve months the share price has lost 68.9%, trading between 0.04 and 0.18.

Tweenvest scores Miro Sciences Ltd across four factors: quality 62/100, value 60/100. Its strongest factor is quality.

MSX price history

Nov 21, 2025 · 0.11Weekly closes 0.04 – 0.15Nov 13, 2026 · 0.04

Key figures

Market cap
$11.09M
Revenue (TTM)
$278.56K
P/E
-3.49
EPS
-0.01
Dividend yield
—
Beta (5Y)
1.31
52-week high
AU$0.18
52-week low
AU$0.04
Avg volume (3M)
—
Shares outstanding
389.72M
Employees
9
Next earnings
—

About Miro Sciences Ltd

Established in 2002 and headquartered in Cottesloe, Australia, NeuroScientific Biopharmaceuticals Limited specializes in the development of medical therapies for neurodegenerative conditions. The company conducts extensive preclinical and clinical research utilizing its proprietary technological platforms to advance these treatments. Its primary pharmaceutical compound, EmtinB, is being developed as a potential therapeutic agent for diseases including neurodegenerative dementia, Alzheimer's disease, and various degenerative disorders affecting the optic nerve.

ISIN
AU0000012973
Founded
2002
Listed since
Jul 27, 2018
Exchange
Australian Securities Exchange
Currency
AUD
CompanyMarket capPriceDay
BioVie Inc.NasdaqCM: BIVI$11.58M$1.08-4.42%
Lisata Therapeutics, Inc.NasdaqCM: LSTA$11.53M$1.28+6.67%
Pharmala Biotech Holdings Inc.CNSX: MDMA$11.16MCA$0.150.00%
Genomtec S.A.WSE: GMT$11.13Mzł2.61-5.62%
Chemomab Therapeutics Ltd.NasdaqCM: CMMB$11.09M$1.53+9.29%
Ceryvyn Therapeutics LimitedASX: CYV$11.07MAU$0.01+20.00%
Onco-Innovations LimitedNEOE: ONCO$10.93MCA$0.23+12.50%
Genomed Spólka AkcyjnaWSE: GEN$10.92Mzł33.00-12.70%

Browse every Biotechnology company →